Celiac Disease
This study is to evaluate the safety and tolerability of single or multiple doses of the investigational drug KAN-101 subjects with confirmed celiac disease.
This study is to evaluate the safety and tolerability of single or multiple doses of the investigational drug KAN-101 subjects with confirmed celiac disease.
Crohn’s Diesase
This study is to evaluate the efficacy and safety of Mirikizumab in patients with moderately to severely active Crohn’s Disease.
This study is to evaluate the efficacy and safety of Mirikizumab in patients with moderately to severely active Crohn’s Disease.
Ulcerative Colitis
This study is to Evaluate safety, tolerability and efficacy of PN-943 treatment in subjects with moderate to severe active ulcerative colitis compared to placebo.
This study is to Evaluate safety, tolerability and efficacy of PN-943 treatment in subjects with moderate to severe active ulcerative colitis compared to placebo.
Ulcerative Colitis
This study is to evaluate the efficacy and safety of induction and maintenance therapy with TD-1473, an orally administered drug, in patients with moderate-to-severe active Ulcerative Colitis (UC).
This study is to evaluate the efficacy and safety of induction and maintenance therapy with TD-1473, an orally administered drug, in patients with moderate-to-severe active Ulcerative Colitis (UC).
Crohn’s Design
This study is to evaluate the efficacy and safety of induction therapy with 2 doses of TD-1473 in patients with moderate-to-severe active Crohn?s Disease (CD).
This study is to evaluate the efficacy and safety of induction therapy with 2 doses of TD-1473 in patients with moderate-to-severe active Crohn?s Disease (CD).